Clinical trial
A Study of TNFerade™ Biologic With Concomitant Radiotherapy, Fluorouracil, and…
NCT00496535 · GenVec, Industry · Completed
Key facts
| NCT number | NCT00496535 |
|---|---|
| Title | A Study of TNFerade™ Biologic With Concomitant Radiotherapy, Fluorouracil, and Hydroxyurea (TNF-FHX) in Patients With Head and Neck Cancer |
| Official title | A Phase I/II Safety, Tolerability, and "Proof of Concept" Study of TNFerade™ Biologic in Combination With Concomitant Radiotherapy, Fluorouracil, and Hydroxyurea (TNF-FHX) for Patients With Unresectable Recurrent Head and Neck Cancer |
| Lead sponsor | GenVec, Industry |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Head and Neck Cancer, Head and Neck Neoplasms |
| Intervention type | Drug |
| Interventions | TNFerade biologic |
| First posted | Jul 4, 2007 |
| Last update posted | Feb 23, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: